Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
Summary
- Primary care providers should understand that modifying antiretroviral therapy in virologically suppressed patients should only be done for a good reason and must be managed with caution, ideally in consultation with an HIV expert
- Reasons for changing therapy may include tolerability, toxicity, preservation of treatment options, or avoidance of drug–drug interactions (Table 1)
- Goal of therapy modification in virologically suppressed patients is to correct the problem with current therapy (eg, toxicity, drug–drug interaction, regimen complexity) while maintaining virologic suppression
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content